An investigation on behalf of investors of Henry Schein, Inc. (NASDAQ:HSIC) shares over potential securities laws violations by Henry Schein, Inc and certain of its directors and officers in connection with certain financial statements was announced.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Henry Schein, Inc. (NASDAQ:HSIC) concerning whether a series of statements by Henry Schein, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

Melville, NY based Henry Schein, Inc. is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. Henry Schein, Inc. Reported that ist Total Revenue rose from over $10.62 billion in 2015 to over $11.57 billion in2016 and its Net Income increased from $479.06 million in 2015 to $506.78 million in 2016.

On February 12, 2018, it was reported that the Federal Trade Commission (FTC) has filed a complaint against the three largest U.S. dental supply companies in the country, including Henry Schein, Inc. The complaint alleges that the companies conspired to prevent dental groups from buying their products in bulk at a discount.

Shares of Henry Schein, Inc. (NASDAQ:HSIC) declined on February 12, 2018 to as low as $63.01 per share.